報價延遲最少15分鐘:2026/09/24 13:15 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.99 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-12.52/2.34
|
|
企業價值
5.52B
|
| 資產負債 |
|
每股賬面淨值
18.13
|
| 現金流量 |
|
現金流量率
0.10
|
| 損益表 |
|
收益
4.25B
|
|
每股收益
33.54
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne. |
